Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Teva
Fish and Richardson
Healthtrust
Queensland Health
Harvard Business School
Boehringer Ingelheim
Cerilliant
Argus Health

Generated: September 25, 2018

DrugPatentWatch Database Preview

GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE Drug Profile

« Back to Dashboard

Which patents cover Granisetron Hydrochloride Preservative Free, and when can generic versions of Granisetron Hydrochloride Preservative Free launch?

Granisetron Hydrochloride Preservative Free is a drug marketed by Bionpharma Inc, Fresenius Kabi Usa, and Teva Pharms Usa. and is included in three NDAs.

The generic ingredient in GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE is granisetron hydrochloride. There are twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the granisetron hydrochloride profile page.

Summary for GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE
Drug patent expirations by year for GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE
Pharmacology for GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE
Synonyms for GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE
007G998
007M998
1-METHYL-1H-INDAZOLE-3-CARBOXYLIC ACID (9-METHYL-9-AZA-BICYCLO[3.3.1]NON-3-YL)-AMIDE HYDROCHLORIDE
1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide hydrochloride
1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1h-indazole-3-carboxamide hydrochloride(1:1)
1-METHYL-N-(9-METHYL-9-AZABICYCLO[3.3.1]NON-3-YL)-INDAZOLE-3-CARBOXAMIDE HCL
1-Methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-indazole-3-carboxamide hydrochloride
1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)indazole-3-carboxamide hydrochloride
1-Methyl-N-(9-methyl-endo-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide monohydrochloride
1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]-3-indazolecarboxamide hydrochloride
1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide hydrochloride
1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide;hydrochloride
1-Methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide hydrochloride
1044956-47-9
107007-99-8
109889-09-0 (Parent)
1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-, monohydrochloride, endo-
1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-,monohydrochloride, endo-
318F6L70J8
A801552
AB0012545
AB0105685
AB2000059
AB53971
AC-478
AC1L22XJ
AC1OCEWF
AC1Q3DY9
AKOS015894931
AKOS025311206
ALM-101
Ambap103639-04-9
AN-5268
API0002865
AS-12882
BC208011
BCP9000731
BEMA-Granisetron
Bio-0050
BRL 43694A
BRL-43694
BRL-43694A
C18H24N4O.HCl
CAS-107007-99-8
CCG-101117
CCG-213056
CHEBI:5538
CHEMBL1237080
CHEMBL1900758
CPD000469138
CS-1510
D00677
D04NLG
DSSTox_CID_28983
DSSTox_GSID_49057
DSSTox_RID_83248
DTXSID7049057
endo-1-Methyl-N-(9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide hydrochloride
FT-0082684
FT-0626806
G0401
Granisertron hydrochloride
Granisetron (Hydrochloride)
Granisetron HCl
Granisetron hydrochloride
Granisetron hydrochloride (JAN/USAN)
Granisetron hydrochloride [USAN:USP]
Granisetron hydrochloride [USAN]
Granisetron hydrochloride, >=98% (HPLC), solid
Granisetron hydrochloride, European Pharmacopoeia (EP) Reference Standard
Granisetron Hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur
Granisetron hydrochloride, United States Pharmacopeia (USP) Reference Standard
Granisetron Hydrocholride
Granisetron-MDTS
Granisol
HY-B0071A
I06-0077
I06-077
J-001688
Kytril
Kytril (TN)
Kytril Injection
LP01173
LS-81436
MCULE-2461768801
MFCD01747034
MFCD21091183
MLS001401373
MLS003915623
NC00367
NCGC00183873-01
NCGC00261858-01
NSC-672814
NSC-759839
NSC672814
NSC759839
Pharmakon1600-01502365
QYZRTBKYBJRGJB-UHFFFAOYSA-N
s1345
SAM001246527
Sancuso
SC-17029
SCHEMBL33433
SCHEMBL34177
SCHEMBL34179
SMR000469138
SMR001456513
ST51051209
SyB L-0701
TL8000249
Tox21_113607
Tox21_501173
UNII-318F6L70J8
W-5272

US Patents and Regulatory Information for GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bionpharma Inc GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE granisetron hydrochloride INJECTABLE;INJECTION 078863-002 Jun 30, 2008 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE granisetron hydrochloride INJECTABLE;INJECTION 078096-001 Jun 30, 2008 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms Usa GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE granisetron hydrochloride INJECTABLE;INJECTION 077165-001 Dec 31, 2007 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Teva
Fish and Richardson
Healthtrust
Queensland Health
Harvard Business School
Boehringer Ingelheim
Cerilliant
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.